Cognitive deficits in Alzheimer's and Parkinson's disease are closely related to disturbed cholinergic transmission. The decrease of nicotinic acetylcholine receptor protein has been assessed by Western blotting and immunohistochemistry. Stereology, however, has not been used to assess numbers of receptor-expressing human cerebrocortical neurons. Our approach applies a combination of ␣7 subunit-immunohistochemistry with a stereological technique using defined stretches of pial surface as reference standard. The number of ␣7 subunit protein-expressing neurons in the Alzheimer temporal cortices amounted to approximately half of that of controls while numbers in Parkinson patients lay in between. No differences in the total number of neurons were seen. These results corroborate nonstereological studies on Alzheimer cortices and for the first time show a similar decrease in receptor expression in Parkinson's disease. They provide evidence that not only Alzheimer dementia but also cognitive deficits in Parkinson's disease may be related to decreased nicotinic receptor expression.
INTRODUCTION
Several lines of evidence point to a reduced number of nicotine binding sites and to a decreased expression of nicotinic acetylcholine receptor (nAChR) proteins in Alzheimer's disease (AD) (for review see Schrö der and Wevers, 1998; cf. Wevers et al., 1999) . Western blotting studies have shown a significant decrease of the amount of ␣4 nAChR protein in AD as compared to controls (40%, Burghaus et al., 1999 Burghaus et al., , 2000 , while studies on the ␣7 subunit are controversial, reporting unchanged (Martin-Ruiz et al., 1999; Guan et al., 2000) or decreased expression (17%; Burghaus et al., 1999 Burghaus et al., , 2000 . Quantitative immunohistochemical studies have revealed a massive reduction in the density of neurons that express the ␣4 and to a lower extent also the ␣7 nAChR protein in AD cortices (Wevers et al., 1999) .
Cognitive deficits as well as a reduction of nicotine binding sites have also been reported in numerous cases of Parkinson's disease (PD) (Rinne et al., 1991) . Our Western blot studies have shown the expression of both the ␣4 and the ␣7 nAChR protein to be reduced in AD as well as in PD (Burghaus et al., 1999) .
What is still lacking, however, is an assumption-free stereological approach which, first, would be useful to
